Cindy Tahl - 01 Jul 2021 Form 4/A - Amendment Insider Report for FATE THERAPEUTICS INC (FATE)

Role: General Counsel and Secretary
Signature: /s/ Cindy Tahl
Issuer symbol: FATE
Transactions as of: 01 Jul 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 27 Jan 2022, 15:04:55 UTC
Date Of Original Report: 02 Jul 2021
Previous filing: 04 Apr 2022
Next filing: 04 Oct 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FATE	Stock Option (Right to Buy)	Options Exercise	$0	-15,383	-7.7%	$0.000000	184,777	01 Jul 2021	Common Stock	15,383	$6.55	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option will be fully exercisable on January 16, 2022.
F2	Corrected ending balance of shares underlying this option as of July 1, 2021.

Remarks:

This amended Form 4 corrects the vesting schedule footnote and the ending balance of this stock option grant as of July 1, 2021. The other transactions reported in the original Form 4 that was filed on July 2, 2021 were correct and are not required to be restated in this amendment.